Cannabis Bioscience International Holdings (CBIH) Operating Income (2022 - 2026)
Cannabis Bioscience International Holdings' (CBIH) quarterly Operating Income came in at -$93259.0 in Q1 2026, up 27.84% year-on-year from -$72951.4 in Q1 2025, and up 2.73% quarter-over-quarter from -$95877.0 in Q4 2025.
Cannabis Bioscience International Holdings (CBIH) Operating Income (2022 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has disclosed Operating Income across 5 years of filings, most recently posting -$93259.0 for Q1 2026.
- Operating Income for Q1 2026 came in at -$93259.0, up 27.84% year-over-year; the trailing twelve-month figure through Feb 2026 was -$398820.0 (down 26.17% YoY), and the FY2025 annual result was -$421365.0, up 13.32% from the prior year.
- Operating Income came in at -$93259.0 for Q1 2026 at Cannabis Bioscience International Holdings, up from -$95877.0 in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$29634.0 in Q2 2024 to a low of -$284866.0 in Q1 2023.
- The 5-year median for Operating Income is -$113419.0 (2024), against an average of -$134968.4.
- Across the five-year window, Operating Income jumped 89.22% in 2024 and tumbled 355.22% in 2025, its largest moves.
- Cannabis Bioscience International Holdings' Operating Income stood at -$183608.0 in 2022, then jumped by 48.53% to -$94512.0 in 2023, then soared by 36.91% to -$59627.0 in 2024, then plunged by 60.79% to -$95877.0 in 2025, then grew by 2.73% to -$93259.0 in 2026.
- The last three Operating Income figures came in at -$93259.0 (Q1 2026), -$95877.0 (Q4 2025), and -$74784.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 14.03 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 193.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -48.28 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -78.32 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 81.33 Mn |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 | -93,259.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -93,259.00 |
| Nov 30, 2025 | -95,877.00 |
| Aug 31, 2025 | -74,784.00 |
| May 31, 2025 | -134,900.00 |
| Feb 28, 2025 | -129,234.00 |
| Nov 30, 2024 | -59,627.00 |
| Aug 31, 2024 | -97,604.00 |
| May 31, 2024 | -29,634.00 |
| Feb 29, 2024 | -159,971.00 |
| Nov 30, 2023 | -94,512.00 |
| Aug 31, 2023 | -176,784.00 |
| May 31, 2023 | -274,898.00 |
| Feb 28, 2023 | -284,866.00 |
| Nov 30, 2022 | -183,608.00 |